Literature DB >> 10640652

Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel.

M Yamamoto1, Y Tabata, L Hong, S Miyamoto, N Hashimoto, Y Ikada.   

Abstract

This paper describes the sustained release of transforming growth factor beta1 (TGF-beta1) from a biodegradable hydrogel based on polyion complexation for the enhancement of bone regeneration activity. Basic TGF-beta1 was adsorbed onto the biodegradable hydrogel of acidic gelatin with an isoelectric point of 5.0 by an electrostatic interaction. The TGF-beta1 could not be adsorbed onto basic gelatin. When acidic gelatin hydrogels incorporating 125I-labeled TGF-beta1 were implanted into the back subcutis of mice, the radioactivity decreased with time and the in vivo retention of TGF-beta1 was prolonged with a decrease in the water content of hydrogels. The higher the water content of hydrogels, the faster their biodegradation. The in vivo retention of TGF-beta1 correlated well with that of gelatin hydrogels, indicating that TGF-beta1 was released from the gelatin hydrogel as a result of hydrogel biodegradation. The ability of TGF-beta1-incorporated into acidic gelatin hydrogels to induce bone regeneration was evaluated in a rabbit calvarial defect model. Eight weeks after treatment, the gelatin hydrogels with water contents of 90 and 95 wt% induced significantly high bone regeneration compared with those with lower and higher water contents and free TGF-beta1. This indicates that the sustained release of TGF-beta1 from the hydrogel with suitable in vivo degradability is necessary to effectively enhance its osteoinductive function. Rapid hydrogel degradation will result in a retention time of TGF-beta1 which is too short to induce bone regeneration. It is possible that the slow degradation of the hydrogel physically blocked TGF-beta1-induced bone regeneration at the skull defect. It can be concluded that the gelatin hydrogel is a promising matrix of TGF-beta1 release to induce skull bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640652     DOI: 10.1016/s0168-3659(99)00129-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB.

Authors:  Guobao Wei; Qiming Jin; William V Giannobile; Peter X Ma
Journal:  J Control Release       Date:  2006-03-03       Impact factor: 9.776

Review 2.  Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.

Authors:  Eduardo K Moioli; Paul A Clark; Xuejun Xin; Shan Lal; Jeremy J Mao
Journal:  Adv Drug Deliv Rev       Date:  2007-04-18       Impact factor: 15.470

3.  Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants.

Authors:  Diederik H R Kempen; Lichun Lu; Kelly L Classic; Theresa E Hefferan; Laura B Creemers; Avudaiappan Maran; Wouter J A Dhert; Michael J Yaszemski
Journal:  J Control Release       Date:  2008-05-13       Impact factor: 9.776

4.  Infiltration and sustenance of viability of cells by amphiphilic biosynthetic biodegradable hydrogels.

Authors:  Finosh Gnanaprakasam Thankam; Jayabalan Muthu
Journal:  J Mater Sci Mater Med       Date:  2014-05-21       Impact factor: 3.896

5.  Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering.

Authors:  S Teixeira; L Yang; P J Dijkstra; M P Ferraz; F J Monteiro
Journal:  J Mater Sci Mater Med       Date:  2010-07-02       Impact factor: 3.896

Review 6.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

7.  Novel role of CCN3 that maintains the differentiated phenotype of articular cartilage.

Authors:  Danilo Janune; Tarek Abd El Kader; Eriko Aoyama; Takashi Nishida; Yasuhiko Tabata; Satoshi Kubota; Masaharu Takigawa
Journal:  J Bone Miner Metab       Date:  2016-11-16       Impact factor: 2.626

8.  Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels.

Authors:  Xuezhong He; Junyu Ma; Esmaiel Jabbari
Journal:  Int J Pharm       Date:  2010-02-26       Impact factor: 5.875

9.  Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Authors:  Toshihiro Kushibiki; Kunio Matsumoto; Toshikazu Nakamura; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

10.  Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin.

Authors:  Lucas A Kinard; Chia-Ye Chu; Yasuhiko Tabata; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.